![Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/615978/fmed-08-615978-HTML/image_m/fmed-08-615978-g001.jpg)
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
![Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis](https://www.frontiersin.org/files/Articles/774079/fmed-08-774079-HTML/image_m/fmed-08-774079-g001.jpg)
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
![Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology](https://fg.bmj.com/content/flgastro/5/3/211/F1.large.jpg)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology
![Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)](https://pub.mdpi-res.com/cells/cells-08-00845/article_deploy/html/images/cells-08-00845-g003.png?1566927131)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis | PLOS ONE
![Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents - ScienceDirect Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1590865820310586-gr1.jpg)
Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents - ScienceDirect
![Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/5/3.cover-source.jpg)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology
![Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)](https://pub.mdpi-res.com/cells/cells-08-00845/article_deploy/html/images/cells-08-00845-ag-550.jpg?1566927131)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
![Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/65646d01-322a-4ab3-bde9-4a5f09044e13/gr1.jpg)
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology
![The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2022/07/08/15/33/nafld-progression-767x535.jpg)